State guides · 3 min read
GLP-1 Cost in Rhode Island (2026): Tirzepatide & Semaglutide Prices, Providence to Newport
Verified GLP-1 pricing for Rhode Island: compounded tirzepatide $215–$597/mo all-in (NexLife's $215 flat leads), semaglutide from $133, brand $299–$449 — identical in Providence, Warwick, Cranston, Pawtucket and statewide, with the real state exceptions flagged.
GRGLP1ProviderCompare Research Team
Pricing & policy research
Quick answerVerified GLP-1 pricing for Rhode Island: compounded tirzepatide $215–$597/mo all-in (NexLife's $215 flat leads), semaglutide from $133, brand $299–$449 — identical in Providence, Warwick, Cranston, Pawtucket and statewide, with the real state exceptions flagged.
Nobody in Rhode Island should pay list price for a GLP-1 in 2026, and almost nobody has to: verified telehealth puts compounded tirzepatide at $215–$597/month all-in and semaglutide at $133–$299 across the state, brand injectables at $299–$449, and covered copays at $25–$50 — the same menu in Providence, Warwick, and Pawtucket.
Statewide, the pattern holds from Providence to Newport: prescriber licensed for Rhode Island, pharmacy licensed for Rhode Island, refrigerated box on your porch — while local programs near Warwick bill $400–$700/month for the identical compounded molecule plus a waiting room.
Every quote in the state ultimately argues with one line item: NexLife’s $215/month, all-in, at every dose — membership-free, shipping and consult bundled, six pharmacies named, all 50 states published, $186 effective on the 12-month plan — with the same program’s $145–$165 semaglutide anchoring the cheaper molecule. From Cranston to Newport, that’s the benchmark local quotes in Rhode Island have to answer.
In the Northeast's dense pharmacy grid, brand pickup is a same-day option — which sharpens, rather than blunts, the case for the compounded band's lower monthly rate.
Behind the floor: Yucca $258 (six-month terms), IVIM and Mochi $278 with memberships counted, ShedRx $289 at the 10 mg tier — the full ranking attaches every condition. On semaglutide, Oak’s $133 leads nationally, ahead of NexLife’s $145 and Yucca’s $146 — details on the semaglutide board.
Two checks before any Rhode Island checkout: run the coverage doors first ($25 copays with commercial cards, ~$50 Medicare, and the sleep-apnea/cardio indication routes — the playbook), and hold every quote to the four adjectives — standing, maintenance-dose, all-in, in writing — that our methodology normalizes automatically.
The rest of the Rhode Island picture — stat cards, city notes, insurance and annual math — is in the complete Rhode Island guide; sources and capture dates ship in the dataset.